228 related articles for article (PubMed ID: 31668356)
1. Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock.
Allen JM; Gilbert BW
Clin Ther; 2019 Dec; 41(12):2594-2610. PubMed ID: 31668356
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock.
Wong A; Alkazemi A; Eche IM; Petri CR; Sarge T; Cocchi MN
J Intensive Care Med; 2020 Dec; 35(12):1490-1496. PubMed ID: 31480886
[TBL] [Abstract][Full Text] [Related]
3. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.
Chawla LS; Busse L; Brasha-Mitchell E; Davison D; Honiq J; Alotaibi Z; Seneff MG
Crit Care; 2014 Oct; 18(5):534. PubMed ID: 25286986
[TBL] [Abstract][Full Text] [Related]
4. Vasopressor therapy in critically ill patients with shock.
Russell JA
Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
[TBL] [Abstract][Full Text] [Related]
5. Vasopressor Therapy in the Intensive Care Unit.
Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Angiotensin II for Catecholamine Refractory Septic or Distributive Shock on Mortality: A Propensity Score Weighted Analysis of Real-World Experience in the Medical ICU.
Quan M; Cho N; Bushell T; Mak J; Nguyen N; Litwak J; Rockwood N; Nguyen HB
Crit Care Explor; 2022 Jan; 4(1):e0623. PubMed ID: 35072084
[TBL] [Abstract][Full Text] [Related]
7. A Blast From the Past: Revival of Angiotensin II for Vasodilatory Shock.
Bissell BD; Browder K; McKenzie M; Flannery AH
Ann Pharmacother; 2018 Sep; 52(9):920-927. PubMed ID: 29582666
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
Knotzer H; Poidinger B; Kleinsasser A
Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis.
Busse LW; Nicholson G; Nordyke RJ; Lee CH; Zeng F; Albertson TE
Int J Technol Assess Health Care; 2020 Apr; 36(2):145-151. PubMed ID: 32114996
[TBL] [Abstract][Full Text] [Related]
10. The Role of Angiotensin II in Poisoning-Induced Shock-a Review.
Chen A; Wong A
J Med Toxicol; 2022 Apr; 18(2):145-154. PubMed ID: 35258848
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II in the treatment of distributive shock: a systematic-review and meta-analysis.
Xourgia E; Exadaktylos AK; Chalkias A; Ziaka M
Shock; 2024 Jun; ():. PubMed ID: 38888542
[TBL] [Abstract][Full Text] [Related]
12. Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin.
Rodriguez R; Cucci M; Kane S; Fernandez E; Benken S
J Intensive Care Med; 2020 Apr; 35(4):327-337. PubMed ID: 30563433
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive vasopressors in distributive shock: How soon is early?
Garcia B; Legrand M
Crit Care; 2023 May; 27(1):210. PubMed ID: 37254175
[No Abstract] [Full Text] [Related]
14. Role of angiotensin II in treatment of refractory distributive shock.
Rodriguez R; Fernandez EM
Am J Health Syst Pharm; 2019 Jan; 76(2):101-107. PubMed ID: 31361800
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients.
Andrews L; Benken J; Benedetti E; Nishioka H; Pierce D; Dalton K; Han J; Shin B; Benken S
Clin Transplant; 2022 Sep; 36(9):e14754. PubMed ID: 35771088
[TBL] [Abstract][Full Text] [Related]
16. FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.
Senatore F; Jagadeesh G; Rose M; Pillai VC; Hariharan S; Liu Q; McDowell TY; Sapru MK; Southworth MR; Stockbridge N
Am J Cardiovasc Drugs; 2019 Feb; 19(1):11-20. PubMed ID: 30144016
[TBL] [Abstract][Full Text] [Related]
17. Vasopressor dose equivalence: A scoping review and suggested formula.
Goradia S; Sardaneh AA; Narayan SW; Penm J; Patanwala AE
J Crit Care; 2021 Feb; 61():233-240. PubMed ID: 33220576
[TBL] [Abstract][Full Text] [Related]
18. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.
Busse LW; McCurdy MT; Ali O; Hall A; Chen H; Ostermann M
Crit Care; 2017 Dec; 21(1):324. PubMed ID: 29282149
[TBL] [Abstract][Full Text] [Related]
19. The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Albertson TE; Chenoweth JA; Lewis JC; Pugashetti JV; Sandrock CE; Morrissey BM
Expert Rev Clin Pharmacol; 2022 Aug; 15(8):959-976. PubMed ID: 35920615
[TBL] [Abstract][Full Text] [Related]
20. Roles of angiotensin II as vasopressor in vasodilatory shock.
Lumlertgul N; Ostermann M
Future Cardiol; 2020 Nov; 16(6):569-583. PubMed ID: 32462921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
